Colossal Biosciences, launched in 2021 by Ben Lamm, has achieved a valuation of $10.2 billion as it pioneers the field of de-extinction, particularly focusing on iconic species such as the woolly mammoth and the dodo. However, the mission is broader than just resurrecting these species; it fundamentally seeks to address biodiversity loss while contributing positively to degraded ecosystems and climatic conditions. In this dialogue moderated by Kc Ifeanyi, Lamm shares insights on how such scientific advancements can become reality and their potential benefits for society at large.
Colossal Biosciences, co-founded by Ben Lamm, aims to reverse biodiversity loss by resurrecting extinct species like the woolly mammoth, promoting ecosystem health and climate regeneration.
Lamm emphasizes that the mission of Colossal extends beyond mere science fiction; it serves as a critical initiative to restore degraded ecosystems and combat imminent ecological threats.
Collection
[
|
...
]